2006
DOI: 10.1634/theoncologist.11-7-801
|View full text |Cite
|
Sign up to set email alerts
|

RFA for Liver Tumors: Does It Really Work?

Abstract: The use of radiofrequency ablation (RFA) is increasing in the treatment of both primary and metastatic hepatic tumors. However, the role of RFA has yet to be clearly defined in patients who are still considered amenable to surgical intervention. Future prospective studies are needed to define whether RFA can be used as an alternative to surgery in certain patient populations. In the interim, radiofrequency ablation technology will continue to advance and serve as both a palliative and potentially curative inte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
21
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(24 citation statements)
references
References 55 publications
1
21
0
Order By: Relevance
“…Complete necrosis was achieved in 68 patients (41%). This procedure is not an anodyne one, literature data suggests morbidty rates under 10% and mortality under 0.5% (59). In our series morbidity was 12% and mortality rate was 1.2%.…”
Section: Discussionsupporting
confidence: 40%
See 1 more Smart Citation
“…Complete necrosis was achieved in 68 patients (41%). This procedure is not an anodyne one, literature data suggests morbidty rates under 10% and mortality under 0.5% (59). In our series morbidity was 12% and mortality rate was 1.2%.…”
Section: Discussionsupporting
confidence: 40%
“…The best results are achieved for tumors no larger than 3 cm, although some authors consider these methods viable for larger tumors (58,59). In our series survival rates were significantly better for patients with tumor diameter of maximum 3 cm (p<0.05) (Fig.…”
Section: Discussionmentioning
confidence: 51%
“…images, hepatic lesions with abnormal metabolic activity are sometimes overlooked [191]. Consequently, local recurrence after liver RFA as a result of these missed tumors remains one of the major factors in relapse [192], which is in the range of 3%-39% [193]. Thus, precise targeting of lesions remains a challenging task when guided solely by volumetric CT with or without contrast enhancement.…”
Section: Motivationmentioning
confidence: 99%
“…Since its acceptance into clinical practice in 1990s, thermal ablation has been widely used as a viable minimally invasive treatment for kidney 1 and liver 2 tumor therapy and is fast becoming the preferred therapy over the standard invasive procedure. In the liver and kidney organs in particular, each and every functional unit-the hepatic acinus in the liver and the nephron in the kidney-that can be saved, counts in a surgeon's attempt to preserve as much functional organ tissue as possible in their oncological patients.…”
Section: Introductionmentioning
confidence: 99%